Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy

Yuan‐Hung Kuo, Chao‐Hung Hung
Alimentary Pharmacology and Therapeutics · Wiley · 2026-10-22 · DOI: 10.1111/apt.70604

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles